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Introduction
The European institutions pay great attention to the
problems of drugs. In this they reflect the general
concern expressed at all levels, from the general public
to specialised international organisations. To supply
effective solutions to this scourge, the institutions have
opted for a comprehensive multidisciplinary approach
tackling the question from every angle: demand reduction,
supply reduction, repression of illicit trafficking and
international action. This strategy obviously integrates at
various complementary levels: within the framework of
Community powers (public health, precursor control,
money laundering, development aid for non-member
countries), within the framework of close cooperation
between Member States (foreign policy, justice and
home affairs), or within the framework of partnership
with numerous international organisations.
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I. The legal framework
A. The European sources
The 1957 Treaty of Rome (as amended by the Single European Act)
already made it possible to tackle the question of drugs within the frame-
work of Community powers. Certain articles of the Treaty provided the
EC (then, the EEC) with a legal basis for action in the context of, for
example, public health protection (Article 152), the common commercial
policy as regards chemical precursors (Article 133) and development
cooperation (Article 179).
But the Union’s commitment to closer, structured cooperation in com-
bating drug abuse found its expression in the Treaty on European Union,
the entry into force of which created new significant opportunities for the
implementation of effective overall strategies. The Union Treaty was the
first instrument allowing the drugs problem to be addressed in an overall
fashion at European level. The point is no longer to implement specific
projects concerning specific policies (public health, commercial policy,
development aid) but to approach the phenomenon in a much broader
and more comprehensive way, in particular under the common foreign
and security policy and by way of cooperation in justice and home
affairs. Here we see the beginning of institutionalised cooperation in the
fight against drugs — the Maastricht Treaty introduced complementarity
between Community and intergovernmental projects in the Union con-
text. The legal framework of the Union Treaty gave the Cannes European
Council a basis for adopting the European Union action plan for the con-
trol of drug abuse for 1995–99. The 2000–04 drug action plan was adopted
by the Feira European Council in June 2000.
Today, the provisions implemented by the Maastricht Treaty represent an
undeniable asset which the new Treaty of Amsterdam (outlined below)
seeks to extend and deepen. The Amsterdam Treaty amends certain
aspects of the Union Treaty to redistribute powers to pursue new objec-
tives. Establishment of the area of freedom, safety and justice enjoys
extremely high priority in the Union. It remains to be seen what fields
will be brought within Community jurisdiction and what fields will be
confined to intergovernmental cooperation. The interest of the Treaty of
Amsterdam, in its approach to drugs, is that it seeks to reconcile an inte-
grated and coordinated approach for the attainment of objectives which
primarily affect sovereignty and the domain reserved for action by States.
Regarding the protection and improvement of public health, Article 152
of the EC Treaty, as amended at Amsterdam, stipulates that ‘The
Community shall complement the Member States’ action in reducing
drugs-related health damage, including information and prevention.’ The
subsidiarity principle is fully applicable and there is no scope for har-
monising the Member States’ health policies. But the new Treaty gener-
ally strengthens the possibilities for Community projects in the field by
adding improvement to the public health prevention aspect. That opens
up the possibility of Community action under the risk reduction approach.
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7B. The international sources
These sources are of two very different legal natures. First, there are
those based on mandatory United Nations instruments. These include the
Single Convention on Narcotics, 1961, as amended by the 1972 protocol,
the Vienna Convention on Psychotropic Substances, 1971, and the United
Nations Convention against Illicit Traffic in Narcotic Drugs and
Psychotropic Substances, 1988. These three instruments impose numerous
obligations on States, within the limits provided for by law, including the
control of lawful drug-related activities, criminalisation of the various
phases of trafficking and criminalisation of money laundering. The
United Nations has also encouraged the approval of multilateral measures
that were not convention-based — and legally not mandatory — which
have had the merit of reminding the Member States of the obligations
they have accepted and setting new priorities for action (measures to be
taken to combat the effects of money generated by illicit drug trafficking,
strengthening of judicial and legal cooperation, etc.) as the drugs phe-
nomenon has intensified.
The 1987 Vienna Conference saw the signing of the comprehensive multi-
disciplinary outline of future activities (CMO), and in 1990 the UN
General Assembly adopted the world action programme, along with a
policy statement by the Member States that they intended to sustain their
efforts to prevent drug abuse and combat illicit trafficking and its side
effects.
8II. The institutional 
framework
Coordination both at Union level and at international level is an essential
component of the policy of combating drug abuse. In addition, under
successive Treaties, the Community institutions have seen their powers
developing as drugs problems have taken on new dimensions. All this
interinstitutional activity, both international and Community, is what we
propose to describe here, though of course the Commission’s role will be
highlighted.
A. The distribution of powers in the Union
institutional set-up
(a) General
In institutional terms, it was in the 1990s that the EU truly manifested its
wish to get involved in drugs problems, including prevention, projects to
reduce illicit trafficking and international development cooperation. In
addition to the three traditional institutions – Council, Commission,
Parliament – which have powers to address this question, new bodies
were set up to respond to specific needs. They are the European
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and
Europol. And it should not be forgotten that beside the Union, the
Council of Europe has also been concerned with these issues, particular-
ly drug abuse. The Pompidou Group, set up informally in 1971 and
institutionalised in the Council of Europe from 1980 onwards, was the
first basis for European cooperation. The Commission is a member of its
group of permanent correspondents.
The Dublin Group, as an informal framework for coordinating interna-
tional assistance in drug abuse control, is another body within which the
Commission is active. It takes part in meetings of the Group, which are
held in Brussels every six months. The Dublin Group, set up in 1990 on
the initiative of the United States, regularly reviews the main develop-
ments in production, consumption and trafficking in the various producing
and transit regions. It is structured as a set of regional formations known
as ‘Dublin mini-groups’. Its members, alongside the 15 Member States
and the Commission, are Canada, the United States, Japan, Australia and
Norway. The UNDCP attends the Dublin Group as an observer.
(b) Commission
Numerous Commission directorates-general have to deal with the prob-
lems of drugs (justice and home affairs, health and consumer protection,
external relations, development, the EuropAid Cooperation Office,
enlargement, internal market, enterprise, taxation and customs union,
OLAF, employment and social affairs, energy and transport, research,
education and culture, Eurostat). To coordinate their activities, a drugs
coordination unit has been set up in the Directorate-General for Justice
and Home Affairs. This unit is supported by the interdepartmental
working party on drugs, involving representatives of the various
directorates-general affected by the drugs phenomenon.
The jurisdiction of the various directorates-general as regards drug abuse
control is outlined below.
Justice and home affairs
Under Title VI of the Union Treaty, cooperation between police and judi-
cial authorities is an essential element in preventing and combating drug
trafficking. The Directorate-General for Justice and Home Affairs accord-
ingly operates the Falcone, OISIN and Grotius programmes on the fight
against organised crime, police and customs cooperation and judicial
cooperation respectively. Beside its purely third-pillar activities, the
Directorate-General for Justice and Home Affairs houses the drug coordi-
nation unit.
Health
One of the functions of Directorate G of the Directorate-General for
Health and Consumer Protection is to support the action taken by the
Member States to reduce the harmful effects of drugs on health (Article
152(1)). It is responsible for implementing the drug addiction prevention
programme soon to be incorporated in the public health programme.
This programme aims to contribute to the fight against drug addiction by,
in particular, encouraging cooperation between Member States, supporting
their action and promoting the coordination of their policies and pro-
grammes with a view to preventing the addiction associated with the use
of narcotics and psychotropic substances, and the related use of other
products.
The family of external relations directorates-general
Directorates-General for External Relations, for Development and for
Enlargement are responsible for the external relations aspects of drugs
policy.
In this context, Directorates-General for External Relations and for
Development are responsible for programming Community aid for third
countries not applying for membership. The EuropAid Cooperation
Office is responsible for identifying, implementing and evaluating these
Community programmes.
The Directorate-General for Enlargement is in charge of relations with the
applicant countries and consequently has responsibility for evaluating
implementation of the acquis communautaire by the applicant countries
and the management of technical assistance programmes for these countries.
The European Commission Delegation to the United Nations in Vienna
devotes much of its activity to providing information and analyses and
facilitating contacts between Commission departments and the main
Vienna-based authorities with powers in matters of drugs (UNDCP, INCB,
Commission on Narcotic Drugs).
The external aspects of European drugs policy are coordinated by an
Inter-Relex coordinator, who chairs the monthly meetings of an inter-
departmental coordination group. 9
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Drug abuse control is a topic included in all cooperation agreements
with third countries. In addition, various regional areas have been iden-
tified as priorities for cooperation on drugs control — the Caribbean and
Latin America, central Asia, southern Africa and west Africa. One of the
aims of the regional agreements is to boost intra-territorial cooperation
between the various relevant national agencies on drugs control by sup-
porting development and setting up national outline plans based on
identified needs and a political commitment by the relevant regions and
countries.
Enterprise
The Directorate-General for Enterprise has specific responsibility for the
implementation by the Community of Council Directive 92/109/EEC on
precursor control. This internal market directive adopted under Article 95
of the EEC Treaty complements Regulation (EEC) No 3677/90 concerning
the control of international trade in precursors. Measures to control new
precursors (not in the annexes to the 1992 directive but used in the pro-
duction of synthetic drugs) are being studied by the Commission.
Taxation and customs union
The Directorate-General for Taxation and the Customs Union is respon-
sible for controls in international trade in precursors under Council
Regulation EEC No 3677/90. It is also responsible for implementation of
the international precursor control agreements concluded by the
Community with eight countries of the Organisation of American States
(Bolivia, Colombia, Ecuador, Peru, Venezuela — 1995; Mexico, United
States — 1997; Chile — 1998).
OLAF
The European Anti-Fraud Office (OLAF) exercises all the powers con-
ferred on the Commission by Community legislation and agreements
with third countries to conduct investigations to reinforce the fight
against fraud, corruption and any other illegal activity to the detriment of
the Union’s financial interests.
Employment and social affairs
The Directorate-General for Employment and Social Affairs, acting under
its EQUAL programme of measures to combat discrimination and
inequalities in employment, supports projects to rehabilitate drug
addicts.
Internal market
The Directorate-General for the Internal Market is in particular responsible
for the questions concerning money laundering. A report on integration
into the national legislation of the principles of Council Directive
91/308/EEC on money laundering is written at least every three years.
And in these times of new technologies, web-based financial and com-
mercial transactions and the resultant questions of security of dealings
and data flows (encryption), it is necessary to strike a balance between
security, confidentiality and maintenance of law and order. Directorate E
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(Free Movement of Information, Intellectual Property, Media and Data
Protection) deals with these questions.
Education and culture
The Directorate-General for Education and Culture is responsible for the
fight against doping. On 16 November 1999 the Commission issued a
communication on a Community support plan to combat doping in sport,
designed to present projects carried out or planned by the Commission
to meet requests formulated by other institutions regarding the fight
against doping. In addition, by means of its education, training and youth
programmes and activities (in particular Socrates, Leonardo da Vinci and
Youth), the Directorate-General for Education and Culture has financed a
number of drug-related projects focusing on access to employment for
young handicapped people or on social rehabilitation and the training of
young people leaving the prison system, or on the fight against drug
addiction as an educational topic.
Research
The Directorate-General for Research aims to strengthen the scientific
and technological bases of the Community industry, to encourage the
development of its international competitiveness and to promote
research projects considered necessary to support the development of
Community policies. Under the fifth framework programme (1998–2002),
two specific budget headings are available for drug-abuse control. They
concern the ‘quality of life’ and ‘competitive and sustainable growth’ pro-
grammes.
Transport
The Directorate-General for Energy and Transport is responsible in par-
ticular for the problems associated with the use of vehicles under the
influence of narcotics. In 1997 the Commission adopted the second
action plan on road safety for the period 1997–2001, with specific priority
placed on the development of roadside checks.
Eurostat
The Statistical Office of the European Communities is also concerned
with drugs in the context of its general remit, which is to provide the
European Union with statistics of high quality. Cooperation between the
EMCDDA and Eurostat (with the aid of the Member States) concerns two
main fields: first, the collection of statistics on the causes of drug-related
deaths, and second, the gathering of health data on drug abuse.
(c) Council
Two Council working groups deal specifically with drug questions. The
purpose of the horizontal working group on drugs, set up in 1997, is to
assure multidisciplinary cross-pillar coordination of Council activities related
to drug-abuse control. Its remit was extended in 1999 to the coordination of
cooperation with third countries as regards drug abuse control. The illicit
trafficking working group, set up in 1999, deals with police cooperation
in the fight against drug trafficking under the third pillar. Several other work-
ing groups are involved where necessary in drug-related activities. For
instance, there is the multidisciplinary group in charge of the fight
against organised crime, the working group on public health, responsible
for implementation of the drug-addiction prevention programme, the
working group on economic questions, which discusses questions
connected with chemical precursor control, the generalised system of
preferences (GSP) working group, which is in charge of implementation
of the system of preferences connected with alternative development aids,
and the customs cooperation working group, the police cooperation
working group, the working group on mutual assistance in criminal
matters, the telecommunications working group and the working
group on financial services — money laundering.
(d) Parliament
Drug-related questions are within the remit of several Parliamentary com-
mittees. They include the committee on citizens’ freedoms and rights,
justice and home affairs, the committee on culture, youth, education, the
media and sport, the committee on the environment, public health and
consumer policy, the committee on employment and social affairs, the
committee on foreign affairs, human rights, common security and
defence policy, the committee on development and cooperation, the
committee on agriculture and rural development, the committee on eco-
nomic and monetary affairs and the committee on industry, external
trade, research and energy.
(e) European Monitoring Centre for Drugs and
Drug Addiction (EMCDDA)
The European Monitoring Centre for Drugs and Drug Addiction, set up
by Council Regulation (EEC) No 302/93 of 8 February 1993, is a
Community agency, i.e. a European public-law entity with legal person-
ality, not provided for by the Treaties but created by an instrument of sec-
ondary legislation to fulfil a specific task defined there.
The role of the EMCDDA is to provide the Community and its Member
States with information that is objective, reliable and comparable at
European level on the phenomena of drugs and drug addiction and their
consequences. It operates on the basis of the European network of infor-
mation on drugs and drug addiction (Reitox), which consists of a focal
point for each Member State and one for the Commission.
Norway has been a member of the EMCDDA since 1 January 2001, and
the Commission has a negotiating brief to associate the applicant coun-
tries in its work. In addition, the EMCDDA has organised partnerships
with various international organisations, in particular the Pompidou
Group, UNDCP, WHO, IDAC, Interpol and Europol, by means of memo-
randa of understanding.
(f) Europol
Europol is an intergovernmental body which aims to improve police
cooperation between Member States for the purposes of combating
terrorism, illicit drug trafficking and other serious forms of international
crime. Within this framework its function is to facilitate the exchange of
information between Member States, gather and analyse information and12
data, communicate to the relevant services of the Member States the
information concerning them and notify them immediately of links ascer-
tained between criminal acts, facilitate investigations in the Member
States and manage computerised databases.
B. The European Union’s partners
The European Union has many partners of different kinds. Some belong
to the United Nations family (the Commission on Narcotic Drugs (CND),
the International Narcotics Control Board (INCB) and the Office for Drug
Control and Crime Prevention (ODCCP)). Others have the status of spe-
cialised international organisation (World Health Organisation (WHO),
Interpol, World Customs Organisation (WCO)) or have a structure which
is not formally institutionalised as such (Financial Action Task Force on
Money Laundering (FATF)). Finally, there are regional organisations such
as the Inter-American Drug Abuse Commission (IDAC).
(a) Commission on Narcotic Drugs
Set up in 1946, this is one of the six technical subcommittees of the
Economic and Social Council of the United Nations and consists of repre-
sentatives of 53 Member States. As specified in its statutes, it is the central
policy-making body within the United Nations system for dealing with all
drug-related matters. It assists the Economic and Social Committee in
supervising the application of the international conventions and agree-
ments dealing with narcotic drugs and psychotropic substances, considers
the changes that may be required in the existing machinery for the inter-
national control of drugs and drafts new international conventions and
instruments. It can also take decisions, on the recommendation of the
World Health Organisation (WHO), on the substances that should be
brought under international control.
(b) International Narcotics Control Board (INCB)
Since the 1961 Single Convention on Narcotic Drugs, international legis-
lation has been strengthened by the 1971 Convention on Psychotropic
Substances and the 1988 Convention against Illicit Traffic in these sub-
stances, which impose numerous obligations on States. Among other
things, they are required to reserve the use of drugs for medical and sci-
entific purposes and to refer to a criminal court all activities connected
with illicit trafficking. Accordingly, it is the responsibility of the
International Narcotics Control Board (INCB) ‘to promote government
compliance with the provisions of the drug control treaties. The Board’s
tasks are laid down in the Treaties. Broadly speaking the Board deals
with two aspects of drug control: With regard to licit manufacture, com-
merce and sale of drugs, the Board endeavours to ensure that adequate
supplies are available for medical and scientific uses (prevention of
diversion) [...] With respect to illicit manufacture and trafficking of drugs,
the Board identifies where weaknesses exist in the national and interna-
tional control systems and contributes to correcting the situation’.
The Board consists of 13 members of recognised independence and
impartiality. They do not exercise their functions as representatives of
their country of origin. Three of them are elected directly by WHO from 13
a list of 10 people proposed by the Member States of the UN or Parties to
the 1961 convention. The Board can be seen as exercising quasi-judicial
functions, since the conventions require it to supervise compliance with
the conventions, assess the performance of States and undertake such
procedures as may be necessary to secure compliance. But requests for
explanations, injunctions and recommendations for embargoes have
never been used.
(c) Office for Drug Control and Crime Prevention
(ODCCP)
In 1997 the United Nations, noting that it was difficult to dissociate illicit
trafficking in drugs from organised crime, decided to combine the United
Nations Drug Control Programme (UNDCP) and the Commission on
Crime Prevention within the same structure (the ODCCP).
The UNDCP was set up in 1991 under United Nations General Assembly
Resolution 45/179 to replace the Fund for the United Nations
International Drug Control Programme. Its main task is to orient and
coordinate all the UN’s drug control activities (information, legal assis-
tance, technical assistance and international cooperation). The
Commission for Crime Prevention deals with criminal matters in the
broadest sense: international drug trafficking, but also corruption, crimes
against minors, international prostitution networks, etc.
(d) World Health Organisation (WHO)
The WHO’s major objective is to contribute to attaining the highest
possible level of health for all. With regard more specifically to WHO
drug-related activities, it must be stressed that this is the only organisation
having the authority to determine what substances must be placed under
international control so that they can be used only for medical and
scientific purposes. The WHO is therefore actively involved in the classifi-
cation of substances in the tables provided for by the conventions, since
it must be able to evaluate ‘the substance, including the likelihood of
abuse, the degree of seriousness of the public health and social problems
and the degree of usefulness of the substance in medical therapy’.
(e) International Criminal Police Organisation
(ICPO) — Interpol
The ICPO-Interpol aims to ensure and develop the broadest mutual assis-
tance of all the criminal police force authorities under the laws existing in
the various countries and in the spirit of the Universal Declaration of
Human Rights, and to establish and develop all the institutions able to
contribute effectively to the prevention and repression of breaches of
law. This organisation was created officially in 1923 and since then the
questions concerning illicit trafficking in narcotic and psychotropic sub-
stances mobilise an important share of its activity and its manpower.
Accordingly, the Drugs Sub-Directorate acts as a clearing-house for the
collection, collation, analysis and dissemination of drug-related information,
coordinating requests for assistance from the National Central Bureaux
(NCB) and helping the specialised State services by coordinating joint
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operations. For several years the Sub-Directorate has also been developing
specific programmes geared to extremely specific problems such as:
• the census of organisations of African traffickers;
• the collection of tactical and strategic information on road-based heroin
trafficking from the Balkans;
• the programme on the marks and logos on cocaine packages.
(f) World Customs Organisation (WCO)
Known as the Customs Cooperation Council until 1994, the World
Customs Organisation (WCO) today has 145 members. As its name indi-
cates, it is an international organisation with powers to deal with all matters
concerning customs cooperation between Member States. The statutes of
the institution require States to tighten their technical assistance so as
coordinate the action of the relevant customs services. The organisation
is responsible, inter alia, for disseminating information on drug seizures
and on the means used by traffickers to mask illicit transport. The WCO
attends meetings of the Commission on Narcotic Drugs with observer status.
(g) Financial Action Task Force on Money
Laundering (FATF)
Set up by the Paris G7 Summit in 1989, the FATF is defined as an ‘inter-
governmental body whose purpose is the development and promotion
of strategies [...] to combat money laundering’, meaning the process of
concealing the illegal origin of the proceeds of crime. Consisting of 26
Member States and two organisations, it holds several meetings each year
at which it ‘(1) monitors members’ progress in implementing anti-money-
laundering measures, thanks to a dual procedure of annual self-evaluation
and more detailed mutual evaluation; (2) reviews money-laundering
techniques and counter-measures; and (3) promotes the adoption and
implementation of anti-money laundering measures globally.’
(h) Inter-American Drug Abuse Control
Commission (IDAC)
On 17 November 1984 the General Assembly of the Organisation of
American States decided to convene a regional conference relating to
drugs-related problems in the American continent. This conference took
place in Rio in April 1986, when the Inter-American Programme of Action
against the illicit use and production of narcotic drugs and psychotropic
substances and traffic therein was adopted. The next conference, which
was held in Guatemala in November 1986, marked the formal establish-
ment of the IDAC.
This Commission of 34 member States aims to promote and facilitate mul-
tilateral cooperation between member States in the control of drugs and
the fight against illicit trafficking, production and use.
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Annex: Acronyms
CATF: Chemical Action Task Force.
CFSP: common foreign and security policy.
CIS: customs information system.
CMO: comprehensive multidisciplinary outline of future activities (UN).
CND: Commission on Narcotic Drugs (UN family).
DEA: Drug Enforcement Administration (United States).
EDF: European Development Fund.
EMCDDA: European Monitoring Centre for Drugs and Drug Addiction.
ERDF: European Regional Development Fund.
EU: European Union.
Europol: European Police Office.
FATF: Financial Action Task Force on Money Laundering.
FBI: Federal Bureau of Investigation (United States).
GHD: horizontal working group on drugs (Council).
GID: interdepartmental working party on drugs (European Commission). 
GSP: generalised system of preferences.
Honlea: Heads of National Drug Law Enforcement Agencies (subsidiary
body of the Commission on Narcotic Drugs).
ICPO/Interpol: International Criminal Police Organisation.
IDAC: Inter-American Drug Abuse Control Commission.
ILO: International Labour Organisation.
INCB: International Narcotics Control Board (UN family).
NDLEA: National Drug Law Enforcement Administration (Nigeria).
Honeycomb: National Institute on Drug Abuse (United States).
OAS: Organisation of American States.
ODCCP: Office for Drug Control and Crime Prevention (UN family).
OECD: Organisation for Economic Cooperation and Development.
OFDT: French Monitoring Centre for Drugs and Drug Addiction.
OLAF: European Anti-fraud Office.
ONDCP: White House Office of National Drug Control Policy (United
States).
Reitox: European information network on drugs and drug addiction.
SADC: Southern Africa Development Cooperation.
SIS: Schengen information system.
UNDCP: United Nations International Drugs Control Programme.
UNDP: United Nations Development Programme.
Ungass: United Nations General Assembly Special Session on Drugs.
WCO: World Customs Organisation.
WHO: World Health Organisation.
WTO: World Trade Organisation.
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